The newly identified aptamers match antibody-level binding strength and could support the development of lower-cost, point-of-care blood tests for neurodegeneration.
Read More
A proof-of-concept study shows that bacteria-metabolized molecules enriched with carbon-13 produce detectable exhaled CO2, enabling rapid infection identification with inexpensive infrared scanners.
Read More
Cirena has licensed a University of Colorado Boulder RNA synthesis technology, enabling scalable production of high-purity, 100–400 nt RNA constructs for CRISPR, functional genomics, and RNA therapeutics research.
Read More
Researchers have validated an IgG ELISA assay for mpox during an active outbreak in Rwanda, enabling distinction between infection- and vaccine-derived immunity, according to findings published in The Lancet Infectious Diseases.
Read More
The WHO has issued its first recommendations for near-point-of-care molecular TB tests, tongue swab specimens, and sputum pooling, aiming to improve diagnostic access and efficiency, according to new consolidated TB guidelines.
Read More